Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Current Opinion in Drug Discovery & Development|April 18, 2007
RNA interference for studying the molecular basis of neuropsychiatric disordersDaniel Hoyer
Neuropharmacology|August 18, 2020
Targeting the 5-HT system: Potential side effectsDaniel Hoyer
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealedDaniel Hoyer
British Journal of Pharmacology|November 5, 2010
Reviewer comments on Reflections on drug research by Sir James BlackDaniel Hoyer
ACS Chemical Neuroscience|March 9, 2017
5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice RapportDaniel Hoyer
British Journal of Pharmacology|June 15, 2025
Psychedelics, entactogens and psychoplastogens for depression and related disordersDaniel Hoyer
Behavioural Brain Research|June 24, 2008
Molecular biology of 5-HT receptorsJason Hannon, Daniel Hoyer
Current Drug Targets|January 2, 2016
Astrocytes: Adhesion Molecules and ImmunomodulationShane Liddelow, Daniel Hoyer
PNAS Nexus|February 7, 2024
The characteristic time scale of cultural evolutionTobias Wand, Daniel Hoyer
Chemistry & Biodiversity|November 20, 2012
Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter SeebachDaniel Hoyer, Tamas Bartfai
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Current Opinion in Drug Discovery & Development|April 18, 2007
RNA interference for studying the molecular basis of neuropsychiatric disordersDaniel Hoyer
Neuropharmacology|August 18, 2020
Targeting the 5-HT system: Potential side effectsDaniel Hoyer
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealedDaniel Hoyer
British Journal of Pharmacology|November 5, 2010
Reviewer comments on Reflections on drug research by Sir James BlackDaniel Hoyer
ACS Chemical Neuroscience|March 9, 2017
5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice RapportDaniel Hoyer
British Journal of Pharmacology|June 15, 2025
Psychedelics, entactogens and psychoplastogens for depression and related disordersDaniel Hoyer
Behavioural Brain Research|June 24, 2008
Molecular biology of 5-HT receptorsJason Hannon, Daniel Hoyer
Current Drug Targets|January 2, 2016
Astrocytes: Adhesion Molecules and ImmunomodulationShane Liddelow, Daniel Hoyer
PNAS Nexus|February 7, 2024
The characteristic time scale of cultural evolutionTobias Wand, Daniel Hoyer
Chemistry & Biodiversity|November 20, 2012
Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter SeebachDaniel Hoyer, Tamas Bartfai
Pageof 16